NLRC5 and neoplasm: DIABLO (permutation test, p < 0.005) identified 15 transcripts in the CD20+ tumor cells (AOIs) to be positively associated with T-cell-rich MCLs (Figure 7, Supplementary Materials Figure S8A), including IL7R, CD47, CD80, CD84 and NLRC5.